These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6977906)

  • 21. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hodgkin's disease: effect of spenectomy on the immune status (author's transl)].
    Diehl V; Schaadt M; Kalden RJ; Hagedorn C; Schmidt N; Deinhardt J
    Klin Wochenschr; 1978 Aug; 56(16):809-18. PubMed ID: 211317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase of T lymphocytes in the spleen in Hodgkin's disease.
    Kaur J; Spiers AS; Catovsky D; Galton DA
    Lancet; 1974 Oct; 2(7884):800-2. PubMed ID: 4138221
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 28. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
    Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor cells in the peripheral blood and spleen of patients with Hodgkin's disease.
    Minassian AA
    Cancer; 1986 May; 57(9):1756-61. PubMed ID: 2937528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
    Begemann M; Claas G; Falke H
    Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
    Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
    Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DNA synthesis in PHA-stimulated lymphocyte cultures from Hodgkin's disease patients and their changes following splenectomy and the effect of chemotherapy treatment using the MOPP scheme].
    Cadel Z
    Nowotwory; 1981; 31(3-4):191-8. PubMed ID: 6896378
    [No Abstract]   [Full Text] [Related]  

  • 35. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Baral E; Blomgren H; Juhlin I
    Cancer; 1979 Oct; 44(4):1241-6. PubMed ID: 498012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.